Evidence map›Paper›PMID 37608192›Full record

ArticleCommunications chemistry2023

Using macromolecular electron densities to improve the enrichment of active compounds in virtual screening.

Wenzhi Ma, Wei Zhang, Yuan Le, Xiaoxuan Shi, Qingbo Xu, Yang Xiao, Yueying Dou, Xiaoman Wang, Wenbiao Zhou, Wei Peng and 2 more

Abstract read
In one paragraph

Article in Communications chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Identification of broad-spectrum MJournal of enzyme inhibition and medicinal chemistry · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wenzhi Ma *Beijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Wei Zhang *State Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, 510182, Guangzhou, China.
Yuan Le *Beijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Xiaoxuan ShiBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Qingbo XuBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Yang XiaoBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Yueying DouBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Xiaoman WangBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Wenbiao ZhouBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China.
Wei PengState Key Laboratory of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, 510182, Guangzhou, China.ORCID http://orcid.org/0000-0002-0949-4487
Hongbo ZhangBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China. zhanghongbo@stonewise.cn.ORCID http://orcid.org/0009-0005-1780-1968
Bo HuangBeijing StoneWise Technology Co Ltd., Haidian Street #15, Haidian District, 100080, Beijing, China. huangbo@stonewise.cn.ORCID http://orcid.org/0000-0003-3822-9110

Funding

Beijing Municipal Science and Technology Commission Z211100003521001
6 · The paper itself

Abstract

The quest for effective virtual screening algorithms is hindered by the scarcity of training data, calling for innovative approaches. This study presents the use of experimental electron density (ED) data for improving active compound enrichment in virtual screening, supported by ED's ability to reflect the time-averaged behavior of ligands and solvents in the binding pocket. Experimental ED-based grid matching score (ExptGMS) was developed to score compounds by measuring the degree of matching between their binding conformations and a series of multi-resolution experimental ED grids. The efficiency of ExptGMS was validated using both in silico tests with the Directory of Useful Decoys-Enhanced dataset and wet-lab tests on Covid-19 3CLpro-inhibitors. ExptGMS improved the active compound enrichment in top-ranked molecules by approximately 20%. Furthermore, ExptGMS identified four active inhibitors of 3CLpro, with the most effective showing an IC

Identifiers

PMID37608192
PMCPMC10444862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.